［1］Gerardo PG,Mathiowitz E.Oral insulin delivery［J］.Adv Drug Deliv Rev,1999,35:249. ［2］陆彬.药物新剂型和新技术［M］.北京：人民卫生出版社，1998. ［3］林其谁.脂质体药物传递系统［J］.生命化学,1999，11(4):564. ［4］Barenholz Y.Liposome application:problems and prospects［J］.Current Opinion in Colloids and Interface Science,2001,6(1):66. ［5］Chen HM,Robert L.Oral particulate delivery:status and future trends［J］.Adv Drug Deliv Rev,1998,34( 2-3):339. ［6］Hara M,Miyake M,Lijima S,et al.Interaction between a novel amphiphilic polymer and liposomes［J］.Supramolecular Science,1998,5(5-6):777. ［7］Iwanaga K,Ono S,Narioka K,et al.Oral delivery of insulin by using surface coating liposomes Improvement of stability of insulin in GI tract［J］.Int J Pharm,1997,157:73. ［8］Kim A,Yun MO,Oh YK,et al.Pharmacodynamics of insulin in polyethylene glycol-coated liposomes［J］.Int J Pharm,1999,180:75. ［9］Silva-Cunha A,Grossiord JL,Puisieux F,et al.W/O/W multiple emulsions of insulin containing a protease inhibitor and an absorption enhancer:preparation,characterization and determination of stability towards proteases in vitro［J］.Int J Pharm,1997,158:79. ［10］Silva-Cunha A,Cheron M,Grossiord JL,et al.W/O/W multiple emulsions of insulin containing a protease inhibitor and an absorption enhancer:biological activity after oral administration to normal and diabetic rats［J］.Int J　Pharm,1998,169:33. ［11］Suzuki A.Enhanced colonic and rectal absorption of insulin using a multiple emulsion containing eicosapentaenoic acid and docosahexaenioc acid［J］.J Pharm Sci,1998,87(10):1196. ［12］吴琼珠，平其能，刘国华.小鼠口服胰岛素复乳后降血糖效果的实验研究［J］.中国医药工业杂志,1990,21(10):445. ［13］Kim K,Mansoor A.Hydrogel delivery systems for vaginal and oral applocation Formulation and biological considerations［J］.Adv Drug Deliv Rev,1993,11:137. ［14］Jung T,Kamm W,Breitenbach A,et al.Biodegradable nanoparticles for oral delivery of peptides:is there a role for polymers to affect mucosal uptake?［J］.Eur J Pharm Biopharm,2000,50:147. ［15］Kim SI,Yamamoto M,Terashima H,et al.Improvement of oral bioavailability of insulin by colon targeting system using azopolymer［J］.Proceed Intern Symp Controlled Release Bioact Mater,1997,24:377. ［16］Carino PG,Jacob SJ,Mathiowitz E.Nanosphere based oral insulin delivery［J］.J Controlled Release,2000,65:261. ［17］Damge C,Michel C.New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier［J］.Diabetes,1988,37:246. ［18］Damge C,Hillarre-Buys D.Effects of orally administrated insulin nanocapsules in normal and diabetic dogs［J］.Diab Nitr Metab,1995,8:3. ［19］Damge C,Vranckx H.Poly(alkylcyanoacrylate) nanospheres for oral-administration of insulin［J］.J Pharm Sci,1997,86(12):1403. ［20］Duan MX,Yue ZC,Ma H,et al.State of insulin encapsulated by polyalkylcyanoacrylate nanoparticles［A］.Polymer preprints papers presented at the Anaheim ［C］.California:American Chemical Society,1999:351～352. ［21］Malam A.Study of the mechanism of insulin encapsulation in poly(isbutylcyanoacrylate) nanocapsules obtained by interfacial polymerization［J］.J Biomed Mater Rev,1999,47:568. ［22］New RRC,Kirby CJ.包含中链单酸甘油酯的疏水性制剂［P］.中华人民共和国国家知识产权局发明专利公开说明书，公开号：CN 1224360A.1999-7-28. ［23］New RRC,Kirby CJ.Solubilisation of hydrophilic drugs in oily formulations［J］.Adv Drug Deliv Rev,1997,25:59. ［24］New RRC,Kirby CJ.Use of an oil-phase carrier-macrosol-for intestinal delivery of peptides in large animals［J］.Proceed Intern Symp Controlled Release Bioact Mater,1996,23:545. ［25］Moses RL,Dileep JK,Sharma PC.Beta cycodextrin-insulin encapsulated chitosan/alginate matrix:oral delivery system［J］.J Appl Polym Sci,2000,75:1089.